Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 2 | -114K | 100% | $33.36 | -$3.81M |
Net | -2 | -114K | -100% | -$3.81M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Ultragenyx Pharmaceutical Inc. | Director | $26.2M | Aug 10, 2021 | ||
Pad Chivukula | Chief Scientific Officer & COO | $9.04M | -$2.2M | -19.6% | Dec 16, 2024 |
Andy Sassine | Chief Financial Officer, Director | $7.06M | -$1.6M | -18.5% | Dec 16, 2024 |
Peter C. Farrell | Director | $3.16M | Jun 14, 2024 | ||
Magda Marquet | Director | $899K | Jun 14, 2024 | ||
James F. Barlow | Director | $421K | Jun 14, 2024 | ||
Edward W. Holmes | Director | $100K | Jun 14, 2024 | ||
Jing L. Marantz | Director | $100K | Jun 14, 2024 | ||
John Markels | Director | $100K | Jun 14, 2024 | ||
Keith C. Kummerfeld | Senior Vice President of Finance (Principal Accounting Officer) | $17.8K | Dec 15, 2023 | ||
Moncef Slaoui | Director | Jun 19, 2024 | |||
Joseph E. Payne | President and CEO, Director | Dec 16, 2024 | |||
Lance Kurata | Chief Legal Officer | Dec 16, 2024 | |||
Karah Herdman Parschauer | Director | Jun 18, 2021 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|